| Thalidomide studied in …STUDIED_INderived200 of 236show all (up to 200) |
|---|
| → studied in | NCT03004287Phase 2 · active not recruiting 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01971658Phase 3 · completed Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04) · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01356290Phase 2 · recruiting Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098475Phase 3 · active not recruiting Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602641Phase 3 · active not recruiting Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07746245Phase 2 · not yet recruiting The Efficacy of CAPCT in Patients With PTCL · 236 trials list this drug (12 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671534Phase 2 · recruiting Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00869232Phase 2 · active not recruiting UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00871013Phase 2 · active not recruiting Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02844309Phase 4 · completed The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM · 236 trials list this drug (12 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02858804Phase 4 · completed EDOCH Alternating With DHAP for New Diagnosed Younger MCL · 236 trials list this drug (12 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00572169Phase 3 · active not recruiting UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07321613completed Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients · 236 trials list this drug (12 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309419Phase 2/Phase 3 · not yet recruiting A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma · 236 trials list this drug (12 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769587completed Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06793475NA · recruiting Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998971Phase 1 · completed A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01539083Phase 3 · completed Velcade (Bortezomib) Consolidation After Transplant · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02507336Phase 2 · completed Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165 · 236 trials list this drug (12 active) | — | — | Non-Hodgkin Lymphoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04352205Phase 2 · terminated Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02586038Phase 2 · completed STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02891811Phase 2 · completed Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06231680Phase 2 · unknown Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) · 236 trials list this drug (12 active) | — | — | Malignant Lung Neoplasm,Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019539Phase 2 · completed Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer · 236 trials list this drug (12 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01661400Phase 1 · completed Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors · 236 trials list this drug (12 active) | — | — | Primitive Neuroectodermal Tumor,Wilms Tumor,Ewing Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06017284Phase 3 · recruiting Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer · 236 trials list this drug (12 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020046Phase 2 · completed Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer · 236 trials list this drug (12 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049673Phase 3 · completed Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03759093Phase 2/Phase 3 · unknown CURATE.AI Optimized Modulation for Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04941937Phase 2 · unknown Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014443Phase 2 · terminated Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054158Phase 2 · completed Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849783Phase 2 · completed Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma,Extraosseous Plasmacytoma,Light Chain Deposition Disease+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266820Phase 2 · unknown Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer · 236 trials list this drug (12 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02424851Phase 2 · completed Optimising Renal Outcome in Myeloma Renal Failure · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01125176Phase 2 · completed Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL · 236 trials list this drug (12 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075829Phase 3 · completed Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112502Phase 2 · completed Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme · 236 trials list this drug (12 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00256776Phase 3 · terminated MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025285Phase 2 · completed Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 236 trials list this drug (12 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049361Phase 2 · completed Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases · 236 trials list this drug (12 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079092Phase 2 · completed Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792142Phase 2 · completed Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538733Phase 2 · completed Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04891744Phase 1/Phase 2 · unknown Selinexor in Combination With Thalidomide and Dexamethasone in RRMM · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02545907Phase 1/Phase 2 · completed A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis · 236 trials list this drug (12 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085655Phase 3 · unknown PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma · 236 trials list this drug (12 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00966693Phase 1/Phase 2 · completed Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04612582Phase 4 · unknown Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis · 236 trials list this drug (12 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033254Phase 3 · completed Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases · 236 trials list this drug (12 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00505635Phase 2 · terminated Biochemotherapy With Temozolomide for Metastatic Melanoma · 236 trials list this drug (12 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274820Phase 2 · completed Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder · 236 trials list this drug (12 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006890Phase 2 · completed Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02733380Phase 2 · unknown Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma · 236 trials list this drug (12 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03608501Phase 2 · withdrawn A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02410694Phase 2 · completed Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00452569Phase 3 · completed Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00657488Phase 2/Phase 3 · completed Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049374Phase 2 · completed Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00041080Phase 3 · completed Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · 236 trials list this drug (12 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025506Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus · 236 trials list this drug (12 active) | — | — | Uterine Corpus Sarcoma,Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025220Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus · 236 trials list this drug (12 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004088Phase 2 · completed Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03062800Phase 2 · unknown Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003) · 236 trials list this drug (12 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01927718NA · terminated Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT) · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00179881Phase 2 · completed Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma · 236 trials list this drug (12 active) | — | — | Primary Brain Stem Neoplasm,Brain Stem Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038181Phase 2 · completed Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer · 236 trials list this drug (12 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00527657Phase 1 · completed Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients · 236 trials list this drug (12 active) | — | — | Melanoma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038090Phase 2/Phase 3 · completed Thalidomide-Dexamethasone for Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038233Phase 3 · completed Thalidomide for Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038246Phase 1/Phase 2 · completed Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma · 236 trials list this drug (12 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400517Phase 2 · completed GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer · 236 trials list this drug (12 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00310076Phase 2 · completed Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer · 236 trials list this drug (12 active) | — | — | Appendix Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064337Phase 2 · completed S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00124579Phase 2 · terminated S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00232934Phase 3 · completed Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00090870Phase 2 · terminated PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer · 236 trials list this drug (12 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01779167Phase 2 · terminated Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia · 236 trials list this drug (12 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526694Phase 2 · completed Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00151281Phase 2 · completed Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma · 236 trials list this drug (12 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006358Phase 2 · completed Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538824Phase 2 · terminated Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004635Phase 3 · completed Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer · 236 trials list this drug (12 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02559154Phase 4 · unknown Modified Bortezomib-based Combination Therapy for Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089609Phase 2 · completed Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer · 236 trials list this drug (12 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089544Phase 2 · terminated Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall · 236 trials list this drug (12 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00287872Phase 2 · completed Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281827Phase 2 · terminated Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer · 236 trials list this drug (12 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01057225Phase 1/Phase 2 · completed Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00307294Phase 2 · completed Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC) · 236 trials list this drug (12 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083915Phase 3 · completed DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03341494Phase 2 · unknown EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide · 236 trials list this drug (12 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081939Phase 2 · completed UARK 2003-33, Total Therapy III · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02248428Phase 3 · unknown Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016000Phase 3 · unknown Thalidomide Maintenance Treatment in DLBCL · 236 trials list this drug (12 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02870036Phase 1 · unknown Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors · 236 trials list this drug (12 active) | — | — | Solid Neoplasm,Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047281Phase 2 · completed Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047294Phase 2 · completed Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00222105Phase 2 · completed A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03204032Phase 2 · unknown A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00182663Phase 2 · completed Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548573Phase 2 · terminated Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026533Phase 2 · completed Thalidomide in Treating Patients With Thyroid Cancer · 236 trials list this drug (12 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01632150Phase 2 · completed Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00097981Phase 3 · completed A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00523848Phase 2 · completed Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040937Phase 2 · completed S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02203253Phase 3 · completed Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting · 236 trials list this drug (12 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02778893Phase 4 · unknown Conmana Combined With Thalidomide to Treat NSCLC · 236 trials list this drug (12 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00406978Phase 1/Phase 2 · completed Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00201357Phase 2 · completed An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450008Phase 2 · terminated Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer · 236 trials list this drug (12 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023530NA · completed Blood and Marrow Transplant Clinical Research Network · 236 trials list this drug (12 active) | — | — | Leukemia,Multiple Myeloma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01551641Phase 2 · unknown Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer · 236 trials list this drug (12 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458705Phase 2 · completed Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02649101Phase 2 · unknown Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer · 236 trials list this drug (12 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083551Phase 3 · completed UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450801Phase 2 · completed R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma · 236 trials list this drug (12 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019747Phase 2 · terminated Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer · 236 trials list this drug (12 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02145715Phase 1/Phase 2 · unknown Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083382Phase 2 · completed Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02467647Phase 1 · unknown The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006016Phase 2 · completed Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery · 236 trials list this drug (12 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577096NA · completed Effects of Exercise in Combination With Epoetin Alfa · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02401971Phase 4 · unknown Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer · 236 trials list this drug (12 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02387086Phase 2/Phase 3 · unknown Gefitinib Combined With Thalidomide to Treat NSCLC · 236 trials list this drug (12 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005834Phase 3 · terminated S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00723658Phase 2 · withdrawn S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia · 236 trials list this drug (12 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01055301Phase 2 · withdrawn S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01537861early Phase 1 · terminated Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098865Phase 2 · completed Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma · 236 trials list this drug (12 active) | — | — | Childhood Central Nervous System Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357500Phase 2 · completed Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer · 236 trials list this drug (12 active) | — | — | Childhood Solid Neoplasm,Leukemia,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004859Phase 3 · terminated Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer · 236 trials list this drug (12 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00142116Phase 2 · completed Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia · 236 trials list this drug (12 active) | — | — | Lymphoplasmacytic Lymphoma,Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00507416Phase 3 · completed Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00215943Phase 3 · terminated Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033332Phase 3 · completed Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00218855Phase 3 · completed Thalidomide to Patients With Previously Untreated Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026416Phase 2 · unknown Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma · 236 trials list this drug (12 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033709Phase 2 · unknown Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma · 236 trials list this drug (12 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096018Phase 1/Phase 2 · completed Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia · 236 trials list this drug (12 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006226Phase 2 · completed Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia · 236 trials list this drug (12 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028886Phase 3 · unknown Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276705Phase 2 · unknown Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer · 236 trials list this drug (12 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004876Phase 2 · completed Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer · 236 trials list this drug (12 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00958854Phase 2 · unknown Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma · 236 trials list this drug (12 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019123Phase 2 · completed Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma · 236 trials list this drug (12 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01924624NA · unknown Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma · 236 trials list this drug (12 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00934154Phase 3 · completed Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027664Phase 2 · unknown Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer · 236 trials list this drug (12 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058487Phase 2 · completed Epirubicin and Thalidomide in Treating Patients With Liver Cancer · 236 trials list this drug (12 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025519Phase 2 · withdrawn Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer · 236 trials list this drug (12 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112879Phase 2 · withdrawn Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma,Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003754Phase 2 · completed Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers · 236 trials list this drug (12 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052416Phase 1 · completed Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia · 236 trials list this drug (12 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053001Phase 2 · completed Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome · 236 trials list this drug (12 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022607Phase 2 · completed Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026520Phase 2 · completed Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma · 236 trials list this drug (12 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006005Phase 2 · completed Thalidomide in Treating Patients With Gynecologic Sarcomas · 236 trials list this drug (12 active) | — | — | Sarcoma,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005815Phase 1/Phase 2 · completed Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma · 236 trials list this drug (12 active) | — | — | Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016224Phase 2 · completed Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer · 236 trials list this drug (12 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027638Phase 2 · completed Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors · 236 trials list this drug (12 active) | — | — | Malignant Lung Neoplasm,Digestive System Neuroendocrine Tumor G1,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00009984Phase 2 · terminated Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer · 236 trials list this drug (12 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258245Phase 1 · completed Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238329Phase 2 · completed PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma · 236 trials list this drug (12 active) | — | — | Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00046826Phase 2 · completed Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy · 236 trials list this drug (12 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008242Phase 2 · completed Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006006Phase 2 · completed Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed · 236 trials list this drug (12 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017316Phase 2 · completed Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma · 236 trials list this drug (12 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003850Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · 236 trials list this drug (12 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379353Phase 2 · completed The Effects of Thalidomide on Symptom Clusters · 236 trials list this drug (12 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030550Phase 2 · completed Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome · 236 trials list this drug (12 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00015912Phase 2 · terminated Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma · 236 trials list this drug (12 active) | — | — | Grade 1 Follicular Lymphoma,Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00015990Phase 2 · completed Thalidomide in Treating Patients With Myelodysplastic Syndrome · 236 trials list this drug (12 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic Syndrome with Ring Sideroblasts,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025467Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer · 236 trials list this drug (12 active) | — | — | Endometrial Adenocarcinoma,Endometrial Carcinoma,Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062127Phase 1 · completed Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors · 236 trials list this drug (12 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072345Phase 2 · completed Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma · 236 trials list this drug (12 active) | — | — | Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072163Phase 2 · completed Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma · 236 trials list this drug (12 active) | — | — | Melanoma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089167Phase 2 · completed Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022581Phase 2 · completed Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma · 236 trials list this drug (12 active) | — | — | Small Lymphocytic Lymphoma,Grade 3 Follicular Lymphoma,Grade 1 Follicular Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104988Phase 2 · completed S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery · 236 trials list this drug (12 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134484Phase 3 · unknown VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM) · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00432458Phase 3 · completed Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227682Phase 2 · terminated Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083005Phase 2 · completed Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate · 236 trials list this drug (12 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412542Phase 2 · completed Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas · 236 trials list this drug (12 active) | — | — | Glioblastoma,Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039468Phase 2 · completed Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy · 236 trials list this drug (12 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047879Phase 2 · completed Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas · 236 trials list this drug (12 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00519688Phase 2 · completed UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma · 236 trials list this drug (12 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00225290Phase 3 · terminated Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve · 236 trials list this drug (12 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00652041Phase 4 · completed Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00263484Phase 2 · completed Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165451Phase 2 · completed A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer · 236 trials list this drug (12 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193102Phase 2 · terminated Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer · 236 trials list this drug (12 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01341262Phase 2 · completed THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM) · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00921531Phase 3 · unknown Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma · 236 trials list this drug (12 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445900Phase 2 · completed Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia · 236 trials list this drug (12 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003894Phase 2 · completed Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant · 236 trials list this drug (12 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602511Phase 3 · completed Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083460Phase 1 · completed Study of Combination PS-341 and Thalidomide in Multiple Myeloma · 236 trials list this drug (12 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |